Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$232,186
12 notices · 213,361 sh
Oct 2025 to Oct 2026
Reported ·
$210,767
7 sales · 13 buys · $442,540 bought
Oct 2025 to Sep 2026
The two figures cover different periods.
None of the 7 reported sales carry the 10b5-1 box. Together they are 0.47% of the shares on issue.
under a no plan named▼ sale▲ buysize is dollars
Form 144 notices, newest first
2026-09-11HARRY KOVELMAN, Chief Medical Officer$20,136
15,844 shno plan date144 ↗ Form 4, 2026-09-14: sold 15,488 at $1.27
Form 4 ↗2026-09-02Morris Milton Mayo, Director$21,150
15,000 shno plan date144 ↗ Form 4, 2026-09-04: sold 15,000 at $1.41
Form 4 ↗2026-08-20HARRY KOVELMAN, Chief Medical Officer$30,329
17,500 shno plan date144 ↗ Form 4, 2026-08-21: sold 17,250 at $1.73
Form 4 ↗2026-07-13David Henry, Chief Financial Officer$5,631
5,166 shno plan dateForm 4s on file end Sep 23144 ↗ 2026-06-12Harry Kovelman, Chief Medical Officer$12,530
10,442 shno plan dateno Form 4 on file144 ↗ 2026-06-12Micah Mitchell, Chief Commercial Officer$10,873
9,061 shno plan dateno Form 4 on file144 ↗ 2026-06-08Harry Kovelman, Chief Medical Officer$10,155
7,635 shno plan dateno Form 4 on file144 ↗ 2026-06-08Micah Mitchell, Chief Commercial Officer$8,684
6,529 shno plan dateno Form 4 on file144 ↗ 2026-05-28HARRY KOVELMAN, Chief Medical Officer$11,734
11,536 shno plan dateno Form 4 on file144 ↗ 2026-05-27HARRY KOVELMAN, Chief Medical Officer$20,468
20,464 shno plan date144 ↗ Form 4, 2026-05-28: sold 32,000 at $1.01
Form 4 ↗2026-05-14MICAH MITCHELL, Chief Commercial Officer$77,689
90,231 shno plan date144 ↗ Form 4, 2026-06-08: sold 90,231 at $0.86
Form 4 ↗2026-04-13David Henry, Chief Financial Officer$2,807
3,953 shno plan dateno Form 4 on file144 ↗